Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
29 August 2020
|
| In: |
Surgery
Year: 2020, Jahrgang: 168, Heft: 6, Pages: 1015-1016 |
| ISSN: | 1532-7361 |
| DOI: | 10.1016/j.surg.2020.07.033 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.surg.2020.07.033 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0039606020305031 
|
| Verfasserangaben: | Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1744893284 | ||
| 003 | DE-627 | ||
| 005 | 20220819080706.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210118s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.surg.2020.07.033 |2 doi | |
| 035 | |a (DE-627)1744893284 | ||
| 035 | |a (DE-599)KXP1744893284 | ||
| 035 | |a (OCoLC)1341388799 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schneider, Martin |d 1976- |e VerfasserIn |0 (DE-588)12390384X |0 (DE-627)706468147 |0 (DE-576)42325037X |4 aut | |
| 245 | 1 | 0 | |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence |c Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD |
| 264 | 1 | |c 29 August 2020 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.01.2021 | ||
| 700 | 1 | |a Neoptolemos, John P. |e VerfasserIn |0 (DE-588)172283302 |0 (DE-627)697192954 |0 (DE-576)133150879 |4 aut | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgery |d Amsterdam [u.a.] : Elsevier, 1995 |g 168(2020), 6, Seite 1015-1016 |w (DE-627)315974907 |w (DE-600)2018278-8 |w (DE-576)093980949 |x 1532-7361 |7 nnas |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence |
| 773 | 1 | 8 | |g volume:168 |g year:2020 |g number:6 |g pages:1015-1016 |g extent:2 |a Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.surg.2020.07.033 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0039606020305031 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210118 | ||
| 993 | |a Editorial | ||
| 994 | |a 2020 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 3 |y j | ||
| 998 | |g 172283302 |a Neoptolemos, John P. |m 172283302:Neoptolemos, John P. |d 910000 |d 910200 |e 910000PN172283302 |e 910200PN172283302 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 998 | |g 12390384X |a Schneider, Martin |m 12390384X:Schneider, Martin |d 910000 |d 910200 |e 910000PS12390384X |e 910200PS12390384X |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1744893284 |e 3838855884 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"name":{"displayForm":["Society of University Surgeons"]},"part":{"pages":"1015-1016","year":"2020","text":"168(2020), 6, Seite 1015-1016","issue":"6","volume":"168","extent":"2"},"corporate":[{"display":"Society of University Surgeons","role":"isb"}],"title":[{"title":"Surgery","title_sort":"Surgery","subtitle":"a monthly journal devoted to the art and science of surgery"}],"language":["eng"],"note":["Gesehen am 19.07.2023"],"origin":[{"dateIssuedDisp":"1995-","publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo.","publisher":"Elsevier ; Mosby","dateIssuedKey":"1995"}],"recId":"315974907","pubHistory":["Nachgewiesen 117.1995 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidenceSurgery","id":{"eki":["315974907"],"zdb":["2018278-8"],"issn":["1532-7361"]}}],"recId":"1744893284","id":{"eki":["1744893284"],"doi":["10.1016/j.surg.2020.07.033"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Martin Schneider, MD, John P. Neoptolemos, MD, Markus W. Büchler, MD"]},"physDesc":[{"extent":"2 S."}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"29 August 2020"}],"note":["Gesehen am 18.01.2021"],"person":[{"family":"Schneider","display":"Schneider, Martin","role":"aut","given":"Martin"},{"role":"aut","given":"John P.","family":"Neoptolemos","display":"Neoptolemos, John P."},{"family":"Büchler","display":"Büchler, Markus W.","role":"aut","given":"Markus W."}],"language":["eng"],"title":[{"title_sort":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence","title":"Commentary: Neoadjuvant treatment of resectable pancreatic cancer: lack of level III evidence"}]} | ||
| SRT | |a SCHNEIDERMCOMMENTARY2920 | ||